Showing results (151-160 of 194) with videos related to

Sort By:
Pageof 20
Seminars in Arthritis and Rheumatism|September 10, 2013
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survivalIrini Flouri, Theodora E Markatseli, Paraskevi V Voulgari, et al.
Open Forum Infectious Diseases|January 6, 2022
Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019Nikolaos Tziolos, Emmanouil Karofylakis, Ioannis Grigoropoulos, et al.
European Geriatric Medicine|October 16, 2021
Self-reported fatigue as a risk index for dementia diagnosisSymeon H Panagiotakis, Panagiotis Simos, Ioannis Zaganas, et al.
RMD Open|June 24, 2026
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort studyKaterina Chavatza, Chrysoula G Gialouri, Konstantinos Drougkas, et al.
Annals of the Rheumatic Diseases|June 24, 2021
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patientsKaterina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, et al.
Annals of the Rheumatic Diseases|July 29, 2022
Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritisEleni Frangou, Panagiotis Garantziotis, Maria Grigoriou, et al.
Journal of Cellular and Molecular Medicine|April 14, 2023
Down-regulation of human long non-coding RNA LINC01187 is associated with nephropathiesTheodora Manolakou, Valeria Kaltezioti, Niki Prakoura, et al.
Annals of the Rheumatic Diseases|November 7, 2024
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathwaysGeorgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathwaysGeorgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Clinical and Experimental Rheumatology|December 2, 2014
Women's health and fertility, family planning and pregnancy in immune-mediated rheumatic diseases: a report from a south-eastern European Expert MeetingStella Ntali, Nemanja Damjanov, Peter Drakakis, et al.
Pageof 20